...
首页> 外文期刊>Korean Circulation Journal >Alterations of beta-Adrenergic Receptor Signaling in Cardiac Hypertrophy and Heart Failure: beta-Adrenergic Receptor Desensitization in Cardiac Disease
【24h】

Alterations of beta-Adrenergic Receptor Signaling in Cardiac Hypertrophy and Heart Failure: beta-Adrenergic Receptor Desensitization in Cardiac Disease

机译:心脏肥大和心力衰竭中β-肾上腺素受体信号的变化:心脏疾病中的β-肾上腺素能受体脱敏

获取原文
           

摘要

beta-adrenergic receptors (betaAR) belong to the large family of G protein-coupled receptors that form the interface between the sympathetic nervous and cardiovascular systems. G protein-coupled receptors undergo adaptation to repeated or prolonged agonist stimulation, which is termed desensitization. Significant betaAR desensitization occurs with the development of cardiac hypertrophy and heart failure, and uncoupling of betaARs and defects in this pathway might be primary elements underlying the transition from compensated to uncompensated cardiac failure. Decreasing the level of myocardial betaARK1 in established heart failure is a novel approach to improving impaired betaAR receptor function, and potentially alter the pathogenesis of this disease.
机译:β-肾上腺素能受体(betaAR)属于G蛋白偶联受体的大家族,它们形成交感神经系统与心血管系统之间的界面。 G蛋白偶联受体经历了对重复或长时间激动剂刺激的适应,这被称为脱敏。随着心脏肥大和心力衰竭的发展,发生了严重的βAR脱敏,βAR与这种途径中的缺陷的脱钩可能是从代偿性心衰向无代偿性心力衰竭过渡的主要因素。降低已确立的心力衰竭中心肌betaARK1的水平是改善受损的betaAR受体功能的一种新方法,并有可能改变这种疾病的发病机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号